Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06660160Not ApplicableActive Not Recruiting

Group Exercise Program Supported By Audiovisual Media During Hemodialysis

Role: collaborator

NCT06376968Not ApplicableRecruiting

Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

Role: lead

NCT06327750Not ApplicableNot Yet Recruiting

The Microcirculation, Dialysis Modality and Sequestered Salt

Role: collaborator

NCT03249532Not ApplicableCompleted

Effect of Dialysis Techniques on Blood Pressure and Cardiac Function During Dialysis

Role: collaborator

NCT02964429Not ApplicableCompleted

Determination In-vivo KUF for Diacap Pro Hemodialyser

Role: lead

NCT01947829Completed

Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)

Role: lead

NCT01840683Not ApplicableCompleted

HELP Therapy for Dry AMD

Role: lead

NCT01111266Not ApplicableCompleted

Determination of in Vivo Ultrafiltration Coefficient (KUF) in Patients With Chronic Kidney Disease (CKD)

Role: lead

NCT01481688Phase 4Unknown

Enhancing Dialysis Adequacy: Effects of Intradialytic Exercise

Role: collaborator

All 9 trials loaded